title: Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase.
abstract: The forkhead transcription factor Foxo3a is able to inhibit cardiomyocyte hypertrophy. However, its underlying molecular mechanism remains to be fully understood. Our present study demonstrates that Foxo3a can regulate cardiomyocyte hypertrophy through transactivating catalase. Insulin was able to induce cardiomyocyte hypertrophy with an elevated level of reactive oxygen species (ROS). The antioxidant agents, including catalase and N-acetyl-L-cysteine, could inhibit cardiomyocyte hypertrophy induced by insulin, suggesting that ROS is necessary for insulin to induce hypertrophy. Strikingly, we observed that the levels of catalase were decreased in response to insulin treatment. The transcriptional activity of Foxo3a depends on its phosphorylation status with the nonphosphorylated but not phosphorylated form to be functional. Insulin treatment led to an increase in the phosphorylated levels of Foxo3a. To understand the relationship between Foxo3a and catalase in the hypertrophic pathway, we characterized that catalase was a transcriptional target of Foxo3a. Foxo3a bound to the promoter region of catalase and stimulated its activity. The inhibitory effect of Foxo3a on cardiomyocyte hypertrophy depended on its transcriptional regulation of catalase. Finally, we identified that myocardin was a downstream mediator of ROS in conveying the hypertrophic signal of insulin or insulin-like growth factor-1. Foxo3a could negatively regulate myocardin expression levels through up-regulating catalase and the consequent reduction of ROS levels. Taken together, our results reveal that Foxo3a can inhibit hypertrophy by transcriptionally targeting catalase.
authors.affiliation: Division of Cardiovascular Research, National Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
authors.forename: Wei-Qi
authors.initials: WQ
authors.lastname: Tan
authors.forename: Kun
authors.initials: K
authors.lastname: Wang
authors.forename: Dao-Yuan
authors.initials: DY
authors.lastname: Lv
authors.forename: Pei-Feng
authors.initials: PF
authors.lastname: Li
mesh_terms: D000818:Animals; D002374:Catalase / Q000378:metabolism*; D000071316:Forkhead Box Protein O3; D051858:Forkhead Transcription Factors / Q000378:metabolism / Q000502:physiology*; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D006984:Hypertrophy; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008954:Models, Biological; D032383:Myocytes, Cardiac / Q000378:metabolism*; D009687:Nuclear Proteins / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species; D015534:Trans-Activators / Q000378:metabolism*; D015533:Transcriptional Activation; D000099251:Myocardin
chemical_list: D002374:Catalase; D000071316:Forkhead Box Protein O3; D051858:Forkhead Transcription Factors; D007334:Insulin-Like Growth Factor I; D009687:Nuclear Proteins; D017382:Reactive Oxygen Species; D015534:Trans-Activators; D000099251:Myocardin; C499517:FOXO3 protein, human; C499515:FOXO3 protein, rat
references.citation: Eur J Clin Invest. 1995 Jul;25(7):529-33
references.pmid: 7556372
references.citation: Circulation. 1999 Jun 8;99(22):2934-41
references.pmid: 10359739
references.citation: Cell. 2004 May 14;117(4):421-6
references.pmid: 15137936
references.citation: Mol Cell Biol. 2008 Jan;28(2):564-74
references.pmid: 17998337
references.citation: Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):669-74
references.pmid: 12515860
references.citation: Circ Res. 2001 Aug 31;89(5):453-60
references.pmid: 11532907
references.citation: Circulation. 2004 Sep 7;110(10):1269-75
references.pmid: 15313952
references.citation: EMBO J. 1999 Nov 1;18(21):6027-36
references.pmid: 10545114
references.citation: Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12333-8
references.pmid: 12237475
references.citation: Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):2153-9
references.pmid: 17034357
references.citation: Nature. 2000 Nov 23;408(6811):492-5
references.pmid: 11100733
references.citation: J Biol Chem. 2002 Jun 21;277(25):22896-901
references.pmid: 11943770
references.citation: Circulation. 2005 Mar 8;111(9):1192-8
references.pmid: 15723974
references.citation: Proc Natl Acad Sci U S A. 2006 May 9;103(19):7432-7
references.pmid: 16651530
references.citation: Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H758-66
references.pmid: 17085541
references.citation: Antioxid Redox Signal. 2007 Jun;9(6):679-87
references.pmid: 17419666
references.citation: Biochem Biophys Res Commun. 2001 Dec 14;289(4):901-7
references.pmid: 11735132
references.citation: Circulation. 2000 Mar 14;101(10):1172-8
references.pmid: 10715265
references.citation: J Biol Chem. 2004 Feb 6;279(6):4782-93
references.pmid: 14597618
references.citation: J Mol Cell Cardiol. 2005 Feb;38(2):375-85
references.pmid: 15698844
references.citation: Biochem J. 2000 Jul 15;349(Pt 2):629-34
references.pmid: 10880363
references.citation: Circulation. 2002 Jan 29;105(4):509-15
references.pmid: 11815436
references.citation: Oncogene. 2005 Nov 14;24(50):7410-25
references.pmid: 16288288
references.citation: Circ Res. 2004 Jun 25;94(12):1533-42
references.pmid: 15217918
references.citation: Circ Res. 2003 Feb 7;92(2):139-50
references.pmid: 12574141
references.citation: Mol Cell. 2002 Aug;10(2):247-58
references.pmid: 12191471
references.citation: Cell. 2004 Apr 30;117(3):399-412
references.pmid: 15109499
references.citation: Biochem Biophys Res Commun. 2004 Oct 1;322(4):1178-91
references.pmid: 15336966
references.citation: J Am Coll Cardiol. 2001 Feb;37(2):676-85
references.pmid: 11216996
references.citation: Mol Cell Biochem. 2000 Sep;212(1-2):155-69
references.pmid: 11108147
references.citation: J Mol Cell Cardiol. 2002 Feb;34(2):233-40
references.pmid: 11851362
references.citation: Circ Res. 2006 Apr 28;98(8):1089-97
references.pmid: 16556869
references.citation: Circ Res. 2000 Feb 18;86(3):255-63
references.pmid: 10679475
references.citation: Cardiovasc Res. 2000 Jul;47(1):23-37
references.pmid: 10869527
references.citation: Circ Res. 2005 Sep 30;97(7):645-54
references.pmid: 16141410
references.citation: J Biol Chem. 2005 May 27;280(21):20814-23
references.pmid: 15781459
references.citation: J Biol Chem. 2008 Jul 11;283(28):19748-56
references.pmid: 18474588
references.citation: J Biol Chem. 2008 Mar 7;283(10):5996-6004
references.pmid: 18171680
references.citation: Am J Physiol Heart Circ Physiol. 2005 Jul;289(1):H17-9
references.pmid: 15961373
references.citation: Circulation. 2006 Sep 12;114(11):1159-68
references.pmid: 16952979
references.citation: Circ Res. 2007 May 25;100(10):1512-21
references.pmid: 17446436
references.citation: Circ Res. 2002 May 31;90(10):1055-63
references.pmid: 12039794
references.citation: Circ Res. 2002 Mar 22;90(5):578-85
references.pmid: 11909822
references.citation: Am J Physiol Heart Circ Physiol. 2006 Aug;291(2):H787-96
references.pmid: 16565309
references.citation: Circ Res. 2003 Dec 12;93(12):1179-92
references.pmid: 14670833
references.citation: Cell. 2000 Dec 8;103(6):843-52
references.pmid: 11136970
references.citation: Genes Dev. 2006 Dec 15;20(24):3347-65
references.pmid: 17182864
references.citation: J Clin Invest. 2007 Nov;117(11):3211-23
references.pmid: 17965779
references.citation: J Clin Invest. 2005 Mar;115(3):500-8
references.pmid: 15765131
references.citation: Circulation. 1998 Aug 25;98(8):794-9
references.pmid: 9727550
references.citation: Genomics. 1998 Jan 15;47(2):187-99
references.pmid: 9479491